# Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

> **NCT07563322** · NA · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07563322
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-09
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-07-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563322, "Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07563322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*